Press release
Comprehensive Biomarker Clinical Phase Outsourcing Services Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034
Biomarker Clinical Phase Outsourcing Services
The biomarker clinical phase outsourcing services market is predicted to grow due to the surge in clinical trials. These research studies, involving human subjects, are designed to determine the efficacy and safety measures of recent medical procedures, treatments, or diagnoses. The amplified volume of clinical trials owes to developments in the medical research sector, the growing incidence of chronic diseases, increased financing from both public and private sectors, and the escalating request for new-age treatments and therapies. Outsourcing providers typically possess specialized proficiency and experience in biomarker discovery, validation, and examination which can amplify the quality and dependability of the biomarker data procured during the trial. As an example, per the United States National Library of Medicine in May 2023, recorded clinical trials saw an increase from 399,499 in 2022 to 437,533 across 50 states and 221 countries. Moreover, the studies registered in the US alone totaled 140,492 (31%) while non-U.S. locations recorded 241,498 studies (53%). Hence, the escalating volume of clinical trials is anticipated to propel the biomarker clinical phase outsourcing services market's growth.
Get Your Biomarker Clinical Phase Outsourcing Services Market Report Here:
https://www.thebusinessresearchcompany.com/report/biomarker-clinical-phase-outsourcing-services-global-market-report
What growth opportunities are expected to drive the biomarker clinical phase outsourcing services market's CAGR through 2034?
In recent times, the biomarker clinical phase outsourcing services market has experienced significant expansion. The market size is projected to surge from $9.71 billion in 2024 to $11.94 billion in 2025, with a compound annual growth rate (CAGR) of 23.0%. Factors contributing to the growth in the historic period include heightened government initiatives and funding, an increase in the diagnostic applications of biomarkers, higher R&D funding from the government, swift progress in technologies like genomics, proteomics and imaging, along with growing demand for cancer biomarkers.
The biomarker clinical phase outsourcing services sector is projected to experience a sizeable expansion in the coming years, accelerating to a value of $27.09 billion by 2029 with a compound annual growth rate (CAGR) of 22.7%. The surge in the forecast period is the result of the growing application of biomarkers in various stages of clinical trials and an escalating demand for precision medicine, backed by a rise in the adoption of companion diagnostics and increasing demand for personalized medicine. The forecast period will also witness key trends including evolved principles in trials, a focus on diagnostic clinical phases, swift progress in biomarker technology, heightened government initiatives and funding, alongside technology advancements.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15740&type=smp
What are the emerging trends shaping the future of the biomarker clinical phase outsourcing services market?
Key players in the biomarker clinical phase outsourcing services industry, are concentrating on advancements in high-throughput flow cytometry and ELISpot testing to secure a competitive advantage in the market. These techniques serve as vital tools for biomarker analysis, enabling quick and accurate evaluation of immune responses and cellular markers. For example, in November 2022, Celerion Inc., a biotechnology outsourcing services company based in the US, broadened its array of services to incorporate GLP/GCP-compliant molecular and cell biology testing. This strategic initiative seeks to augment Celerion's capacity to assist clients throughout the drug development trajectory, from preliminary clinical research to regulatory filings. By incorporating GLP/GCP-compliant molecular and cell biology examinations, such as pharmacokinetic (PK), pharmacodynamic (PD), and biomarker analysis, Celerion is able to offer a wider range of services. This expansion allows Celerion to support their clients in the creation of high-standard data necessary to meet regulatory mandates, thus accelerating the creation of new drugs.
Which growth-oriented segments of the biomarker clinical phase outsourcing services market are leading the industry's development?
The biomarker clinical phase outsourcing services market covered in this report is segmented -
1) By Type: Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types
2) By Service Type: Biomarker Validation, Biomarker Testing Services, Biomarker Sample Analysis
3) By Therapeutic Area: Oncology, Neurology, Cardiology, Autoimmune Diseases, Other Therapeutic Areas
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions
Subsegments:
1) By Surrogate Endpoints: Tumor Marker-Based Endpoints, Imaging-Based Endpoints, Genetic or Genomic Markers
2) By Predictive Biomarker: Genetic Predictive Biomarkers, Protein Predictive Biomarkers, Metabolomic Predictive Biomarkers
3) By Prognostic Biomarker: Cancer Prognostic Biomarkers, Cardiovascular Prognostic Biomarkers, Neurological Prognostic Biomarkers
4) By Safety Biomarker: Toxicity Biomarkers, Adverse Drug Reaction Biomarkers, Drug Interaction Biomarkers
5) By Other Biomarker Types: Inflammation Biomarkers, Infectious Disease Biomarkers, Autoimmune Disease Biomarkers
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15740
What regions are leading the charge in the biomarker clinical phase outsourcing services market?
North America was the largest region in the biomarker clinical phase outsourcing services market in 2023. The regions covered in the biomarker clinical phase outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What companies are at the forefront of innovation in the biomarker clinical phase outsourcing services market?
Major companies operating in the biomarker clinical phase outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15740&type=smp
What Is Covered In The Biomarker Clinical Phase Outsourcing Services Global Market Report?
•Market Size Forecast: Examine the biomarker clinical phase outsourcing services market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the biomarker clinical phase outsourcing services market for a structured understanding.
•Key Players Overview: Analyze major players in the biomarker clinical phase outsourcing services market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the biomarker clinical phase outsourcing services market.
•Segment Contributions: Evaluate how different segments drive overall growth in the biomarker clinical phase outsourcing services market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the biomarker clinical phase outsourcing services market.
•Industry Challenges: Identify potential risks and obstacles affecting the biomarker clinical phase outsourcing services market.
•Competitive Landscape: Review strategic developments in the biomarker clinical phase outsourcing services market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Biomarker Clinical Phase Outsourcing Services Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here
News-ID: 3920159 • Views: …
More Releases from The Business Research Company
Diabetic Neuropathy Industry Report 2025-2034: Market Dynamics, Trends, And Fore …
The Diabetic Neuropathy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Diabetic Neuropathy Market Size During the Forecast Period?
The market scale for diabetic neuropathy has seen a significant expansion in the past few years. Its growth is projected to rise from…
Evolving Market Trends In The Dental Restorative And Regenerative Material Indus …
The Dental Restorative And Regenerative Material Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dental Restorative And Regenerative Material Market Size During the Forecast Period?
The market size for dental restorative and regenerative material has seen substantial growth in the recent past.…
Surge In Data Traffic Drives The Data Center Server Market: Key Factor Driving T …
The Data Center Server Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Data Center Server Market Size During the Forecast Period?
The size of the data center server market has consistently expanded over the recent years. The market is projected to increase…
Cryocooler Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
The Cryocooler Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Cryocooler Market Size During the Forecast Period?
The market size of cryocoolers has seen significant growth in the past few years. It is expected to increase from $3 billion in 2024 to…
More Releases for Biomarker
Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF (including full…
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the…
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period.
A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis…
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core…
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports.
The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and…
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological…
